-+ 0.00%
-+ 0.00%
-+ 0.00%

EQUILLIUM INC -PHASE 2 ULCERATIVE COLITIS STUDY RECENTLY COMPLETED; TOPLINE DATA EXPECTED Q1 2025

Reuters·11/13/2024 21:01:00

Please log in to view news